Código QR (código de barras bidimensional)

MRPL3 is identified as a prognostic biomarker and therapeutic target in lung adenocarcinoma via a lactylation-disulfidptosis gene signature model and experimental validation

BackgroundLung adenocarcinoma (LUAD), the most prevalent histological subtype of lung cancer, is a leading cause of global cancer mortality. Its pronounced heterogeneity poses a critical challenge, creating an urgent need for reliable biomarkers to accurately predict patient prognosis. Here, we focu...

ver descrição completa

Na minha lista:
Principais autores: Lan Yin, Rui Tang, Yue Song, Yunqiang Liu, Yongxin Ma
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-05-01
coleção:Frontiers in Immunology
Assuntos:
biomarkers
disulfidptosis
lactylation
LUAD
Mrpl3
prediction of prognosis
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1772955/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados